CGTX
COGNITION THERAPEUTICS INC
NASDAQ · Healthcare · Biotechnology · US
$0.73
−0.33%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.09x
- Price / sales
- —
- Price / cash flow
- -3.91x
Enterprise value
- Enterprise value
- $35.7M
- EV / sales
- —
- EV / EBITDA
- -2.16x
- EV / EBIT
- -0.97x
- Market cap
- $69.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026